DR. JOE BRICE WEINBERG, M.D.
Osteopathic Medicine at Fulton St, Durham, NC
License number
North Carolina 23453
Category
Osteopathic Medicine
Type
Hematology
Address
Address
508 Fulton St, Durham, NC 27705
Phone
(919) 286-0411
Personal information
See more information about JOE BRICE WEINBERG at radaris.comName
Address
Phone
2617 Snow Hill Rd, Durham, NC 27712
Durham, NC
2617 Snow Hill Rd, Durham, NC 27712
Professional information
Dr. Joe B Weinberg, Durham NC - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
VA Medical Center Durham
508 Fulton St, Durham 27705
(919) 286-0411 (Phone)
Durham VA Med Cntr Hemtlgy/Onco
508 Fulton St, Durham 27705
(919) 286-6944 (Phone)
508 Fulton St, Durham 27705
(919) 286-0411 (Phone)
Durham VA Med Cntr Hemtlgy/Onco
508 Fulton St, Durham 27705
(919) 286-6944 (Phone)
Certifications:
Hematology, 1976, Internal Medicine, 1974, Medical Oncology, 1977
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Arkansas For Medical Sciences
Graduated: 1969
U Hosp
U Ark
University Of Utah
University of Arkansas For Medical Sciences
Graduated: 1969
U Hosp
U Ark
University Of Utah
Method And Agent For Inducing Apoptosis/Cell Death In Leukemia Cells
US Patent:
2009018, Jul 23, 2009
Filed:
Dec 29, 2008
Appl. No.:
12/318349
Inventors:
Joe Brice Weinberg - Durham NC, US
Marc Christopher Levesque - Sewickley PA, US
Dipak Kumar Ghosh - Durham NC, US
Marc Christopher Levesque - Sewickley PA, US
Dipak Kumar Ghosh - Durham NC, US
Assignee:
U.S. DEPARTMENT OF VETERANS AFFAIRS - WASHINGTON DC
International Classification:
A61K 31/4164, A61K 31/416, A61K 31/381, A61K 31/155, A61P 35/02
US Classification:
514396, 514403, 514448, 514637
Abstract:
A method for inducing apoptosis or cell death in leukemia cells includes inhibiting the production of nitric oxide (NO) by using a nitric oxide synthase (NOS) inhibitor. The NOS inhibitor includes a NOS1-specific inhibitor, such as N-[4-(2-{[(3-chlorophenyl)methyl]amino}ethyl)phenyl]-2-thiophenecarboximide dihydrochloride, [N-(1-imino-3-butenyl)-L-ornithine], 7-nitroindazole, 1-(2-trifluoromethylphenyl)imidazole, 3-bromo-7-nitroindazole, and S-ethyl-N-[4-(trifluoromethyl)phenyl)isothiourea HCl.
Joe Weinberg, Durham NC
Specialties:
Internal Medicine, Hematology, Medical Oncology, Hematology
Work:
Durham Va Medical Center
508 Fulton St, Durham, NC 27705 Private Diagnostic Clinic
Va Med Ctr Erwin Rd, Durham, NC 27710
508 Fulton St, Durham, NC 27705 Private Diagnostic Clinic
Va Med Ctr Erwin Rd, Durham, NC 27710
Education:
University of Arkansas(1969)
Method And Agent For Inducing Apoptosis/Cell Death In Leukemia Cells
US Patent:
2005023, Oct 20, 2005
Filed:
Nov 9, 2004
Appl. No.:
10/983978
Inventors:
Joe Weinberg - Durham NC, US
Marc Levesque - Durham NC, US
Dipak Ghosh - Durham NC, US
Marc Levesque - Durham NC, US
Dipak Ghosh - Durham NC, US
International Classification:
A61K031/573, A61K031/4172, A61K031/416, A61K031/381, A61K031/198
US Classification:
514171000, 514400000, 514406000, 514447000, 514565000
Abstract:
A method for inducing apoptosis or cell death in leukemia cells includes inhibiting the production of nitric oxide (NO) by using a nitric oxide synthase (NOS) inhibitor, or the actions of NO by a NO quencher/scavenger. The NOS inhibitor includes a NOS1-specific inhibitor, such as N-[4-(2-{[(3-chlorophenyl)methyl]amino}ethyl)phenyl]-2-thiophenecarboximide dihydrochloride, [N-(1-imino-3-butenyl)-L-ornithine], 7-nitroindazole, or 1-(2-trifluoromethylphenyl)imidazole. The examples of NO quencher/scavenger include 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide and hydroxocobalamin.
Methods Of Inhibiting Nitric Oxide Synthase Using Corrin Derivatives
US Patent:
2008015, Jun 26, 2008
Filed:
Sep 28, 2007
Appl. No.:
11/904747
Inventors:
Joe Brice Weinberg - Durham NC, US
Dipak Kumar Ghosh - Durham NC, US
Dipak Kumar Ghosh - Durham NC, US
International Classification:
A61K 31/555, A61P 43/00
US Classification:
514186
Abstract:
The present invention provides methods of inhibiting nitric oxide synthase (NOS) using corrin derivatives that bind NOS but do not bind NO. It also provides methods of inhibiting NOS in vivo by administering corrin derivatives, and methods of treating diseases and medical conditions using this inhibition of NOS.
Use Of Polymer D-Lactic Acid (Pdla) Or Equivalents Thereof To Inhibit Growth Of Cancer Cells And Diagnose Cancers
US Patent:
2012019, Aug 2, 2012
Filed:
Jan 27, 2012
Appl. No.:
13/360567
Inventors:
Joel S. Goldberg - Durham NC, US
Joe Brice Weinberg - Durham NC, US
Joe Brice Weinberg - Durham NC, US
International Classification:
A61K 31/765, A61K 31/225, C08G 63/06, G01N 33/566, A61P 35/00, C12N 5/09, C07C 69/68
US Classification:
424 7837, 435375, 514547, 560180, 435 71, 528361
Abstract:
The invention provides method for sequestering or trapping L-lactate in or near a tumor cell comprising contacting an isolated polymer of D-lactic acid (PDLA) or an equivalent, derivative or analog thereof with the tumor cell so that the PDLA binds L-lactate in or near the cell and thereby sequestering or trapping L-lactate in or near the tumor cells.